|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
01/17/2024 |
$58.91 |
$59.25 |
$58.75 |
$58.87 |
549.40K | 01/18/2024 |
$58.91 |
$58.92 |
$58.80 |
$58.82 |
321.20K | 01/19/2024 |
$58.76 |
$59.15 |
$58.64 |
$58.80 |
2.07M | 01/22/2024 |
$58.86 |
$58.99 |
$58.54 |
$58.70 |
20.99M | 01/23/2024 |
$58.70 |
$58.70 |
$58.70 |
$58.70 |
0 |
|
Mirati Therapeutics is a clinical-stage oncology company developing therapeutics to address the genetic and immunological promoters of cancer. Co.'s product candidates include: Adagrasib, an investigational, selective, specific, potent and orally available KRAS G12C inhibitor in clinical development as a monotherapy and in combination with other agents; MRTX1133, an investigational, selective, specific and potent KRAS G12D inhibitor in preclinical development; Sitravatinib, an investigational spectrum-selective kinase inhibitor; and MRTX1719, an internally discovered investigational synthetic lethal PRMT5 inhibitor to target the PRMT5/methylthioadensoine complex in preclinical development. | |
|
Mirati Therapeutics (MRTX) has the following price history information. Looking back at MRTX historical stock prices for the last five trading days, on January 17, 2024, MRTX opened at $58.91, traded as high as $59.25 and as low as $58.75, and closed at $58.87. Trading volume was a total of 549.40K shares. On January 18, 2024, MRTX opened at $58.91, traded as high as $58.92 and as low as $58.80, and closed at $58.82. Trading volume was a total of 321.20K shares. On January 19, 2024, MRTX opened at $58.76, traded as high as $59.15 and as low as $58.64, and closed at $58.80. Trading volume was a total of 2.07M shares. On January 22, 2024, MRTX opened at $58.86, traded as high as $58.99 and as low as $58.54, and closed at $58.70. Trading volume was a total of 20.99M shares. On January 23, 2024, MRTX opened at $58.70, traded as high as $58.70 and as low as $58.70, and closed at $58.70. Trading volume was a total of 0 shares.
MRTX Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Mirati Therapeutics shares, starting with a $10,000 purchase of MRTX, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/01/2014 |
|
End date: |
01/23/2024 |
|
Start price/share: |
$19.50 |
|
End price/share: |
$58.70 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
201.03% |
|
Average Annual Total Return: |
11.88% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$30,109.88 |
|
Years: |
9.82 |
|
|
|
Date |
Close |
01/17/2024 | $58.87 | 01/18/2024 | $58.82 | 01/19/2024 | $58.80 | 01/22/2024 | $58.70 | 01/23/2024 | $58.70 |
|
|